SCHEMBL25535291

SCHEMBL25535291

c1ccc(-c2ccc(-c3nc(-c4cccc5ccccc45)cc(-c4ccc(-c5cccc6c5-c5ccccc5C6(c5ccccc5)c5ccccc5)c5ccccc45)n3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
MAPT P10636 4/20 0.38
HPGD P15428 4/20 0.38
KDM4E B2RXH2 3/20 0.38
MAPK1 P28482 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
ATM Q13315 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
NTSR1 P30989 1/20 0.33
CA12 O43570 3/20 0.33
CA1 P00915 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25535253 0.98 ALDH1A1 (0.39) ALDH1A1MAPTHPGDKDM4EMAPK1
SCHEMBL25538137 0.95 ALDH1A1 (0.38) ALDH1A1MAPTHPGDKDM4EMAPK1
SCHEMBL25535296 0.95 MEN1 (0.36) ALDH1A1MAPTHPGDKDM4EMAPK1
SCHEMBL25535273 0.94 MEN1 (0.40) ALDH1A1MAPTHPGDKDM4EMAPK1
SCHEMBL25535395 0.94 MEN1 (0.40) ALDH1A1MAPTHPGDKDM4EMAPK1
SCHEMBL25535262 0.94 MEN1 (0.40) ALDH1A1MAPTHPGDKDM4EMAPK1
SCHEMBL25535351 0.94 MEN1 (0.40) ALDH1A1MAPTHPGDKDM4EMAPK1
SCHEMBL25535522 0.93 MEN1 (0.34) ALDH1A1MAPTHPGDKDM4EMAPK1
SCHEMBL25535361 0.93 ALDH1A1 (0.38) ALDH1A1MAPTHPGDKDM4EMAPK1
SCHEMBL25535321 0.93 MAOB (0.34) ALDH1A1MAPTHPGDKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM ALDH1A1 254/4885MAPT 1595/4885HPGD 3854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.